期刊文献+

慢性收缩性心力衰竭患者血尿酸浓度改变及其与氧化应激的关系研究 被引量:4

Relationship between the level of uric acid and oxidative stress in patients with chronic systolic heart failure
下载PDF
导出
摘要 目的研究慢性收缩性心力衰竭(CSHF)患者血尿酸(UA)浓度改变与心功能及谷胱甘肽抗氧化系统的关系。方法选择2006年6月至2007年3月109例患者,根据有无器质性心脏病及心功能情况分为CSHF组81例,对照组28例,CSHF组又按纽约心脏病协会(NYHA)心功能分级分为心功能Ⅱ级组28例,心功能Ⅲ级组28例,心功能Ⅳ级组25例。所有患者均于入院第2天采空腹静脉血,应用酶循环法测定血浆还原型谷胱甘肽(GSH)、氧化型谷胱甘肽(GSSG)浓度,并利用Nemst公式计算氧化还原电位Eh值。结果CSHF组患者血UA浓度[(499.09±168.04)umol/L]较对照组[(310.54±99.92)umol/L]明显升高(P〈0.01),且随着心功能分级的增加而升高,与LVEF呈负相关(r=-0.247,P=0.026),与左室舒张末期内径(LVEDD)呈正相关(r=0.266,P=0.016)。血UA浓度与血浆C.SH浓度呈负相关(r=-0.328,P=0.003),与血浆GSSG浓度呈正相关(r=0.244,P=0.028),与Eh值呈正相关(r=0.309,P=0.005)。结论CHF时血UA浓度升高,且与心功能分级、LVEF、LVEDD存在相关眭,可作为反映收缩性心功能不全患者心功能状态的补充指标;血UA浓度还与血浆GSH浓度呈负相关、与血浆GSSG浓度及Eb值呈正相关,结合CSHF时UA的代谢途径,提示UA有可能作为氧化应激的指标。 Objective To study the relationship between the level of uric acid and oxidative stress in patients with chronic systolic heart failure (CSHF). Methods One hundred and nine hospitalized patients from June 2006 to March 2007 were selected. Based on organic heart disease and heart function, they were classified into two groups: CSHF group (81 cases) and control group (28 cases). According to NYHA heart function grade ( Ⅱ, Ⅲ, Ⅳ ), CSHF group was divided into three subgroups. The plasma concentration of GSH and GSSG was determined by using glutathione reductase recycling method (GR-DTNB). Redox potential (Eh) was calculated using Nemst equation according to the concentration of reduced and oxidized glutathione. Results There was significant difference between control group and CSHF group in the level of uric acid [ (310.54 ±99.92) umol/L vs (499.09 ± 168.04)umol/L], P 〈 0.01. Uric acid had a negative correlation with LVEF (r = -0.247 ,P = 0.026), and a positive correlation with LVEDD (r = 0.266,P = 0.016). The concentration of uric acid had a negative correlation with GSH (r = -0.328 ,P = 0.003 ), and a positive correlation with GSSG (r = 0.244,P= 0.028) and Eh (r = 0.309,P= 0.005). Conclusions The concentration of uric acid increases in CSHF patients and has a correlation with LVEF and LVEDD. It may be a supplementary marker to reflect heart function and the serious degree of CSHF. The concentration of uric acid has a negative correlation with GSH, and a positive correlation with GSSG and the value of Eh. It may be used as an indicator of oxidative stress concem'ing its metabolic pathway.
作者 刘新叶 李勋
出处 《中国医师进修杂志(内科版)》 2008年第10期15-18,共4页 Chinese Journal of Postgraduates of Medicine
关键词 谷胱甘肽 氧化还原 尿酸 慢性收缩性心力衰竭 Glutathione Oxidation-reduction Uric acid Chronic systolic heart failure
  • 相关文献

参考文献7

  • 1Jankowska EA, Ponikowska B, Majda J, et al. Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure. Int J Cardiol, 2007, 115(2): 151-155.
  • 2Nieto FJ,Iribarren C,Gross MD, et at. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis, 2000,148(1):131-139.
  • 3Glantzounis GK,Tsimoyiannis EC, Kappas AM, et al. Uric acid and oxidative stress. Curr Pharm Des, 2005, 11 (32):4145-4151.
  • 4谭来勋,李言,叶心国.急性脑血管病患者血尿酸水平的研究[J].中国实用内科杂志,2000,20(12):740-741. 被引量:57
  • 5Freeman LM, Rush JE, Milbury PE, et al. Antioxidant status and biomarkers of oxidative stress in dogs with congestive heart failure. J Vet Intern Med, 2005, 19(4):537-541.
  • 6Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med, 2001, 30( 11 ):1191-1212.
  • 7Ekelund UE, Harrison RW, Shokek O, et al. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. Cire Res, 1999, 85(9): 437-445.

二级参考文献2

  • 1孙丽沙 杨露春 等.急脑局灶性缺血后细胞凋亡的动态变化[J].卒中神经疾病杂志,1998,5(2):116-116.
  • 2孙丽沙,卒中与神经疾病,1998年,5卷,2期,116页

共引文献56

同被引文献24

  • 1Arita Y,Kihara S,Ouchi N,et al.Paradoxical decrease of an adipose-specific protein,adiponectin,in obesity.Biochem Biophys Res Commun,1999,257(1):79-83.
  • 2Kumada M,Kihara S,Sumitsuji S,et al.Association of hypoadiponectinemia with coronary artery disease in men.Arterioscler Thromb Vasc Biol,2003,23(1):85-89.
  • 3Ceorge J,Patal S,Wexler D,et al.Circulating adiponectin concentrations in patients with congestive heart failure.Heart,2006,92(10):1420-1424.
  • 4Tanaka T,Tsutamoto T,Nishiyama K,et al.Impact of oxidative gtress on plasma adiponectin in patients with chronic heart failure.Circ J,2008,72(4):563-568.
  • 5Fischer P,Hilfiker-Kleiner D.Survival pathways in hypertrophy and heart failure:the gp130-STAT3 axis.Basic Res Cardiol,2007,102(4):279-297.
  • 6Rutschow S,Li J,Schultheiss HP,et al.Myocardial proteases and matrix remodeling in inflammatory heart disease.Cardiovasc Bes,2006,69(3):646-656.
  • 7Prabhu SD.Cytokine-induced modulation of cardiac function.Circ Res,2004,95(12):1140-1153.
  • 8Ouchi N,Walsh K.Adiponectin as an anti-inflam matory factor.Clin Chim Acta,2007,380(12):24-30.
  • 9Jankowska EA,Ponikowska B,Majda J,et al.Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure.Int J Cardiol,2007,115(2):151-155.
  • 10Motoshima H,Wu X,Mahadev K,et al.Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL.Biochem Biophys Bes Commun,2004,315(2):264-271.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部